top of page
Lantheus_Logo_TM_RGB_Boxed.png

Lantheus is a leading radiopharmaceutical-focused company with proven expertise in developing, manufacturing and commercializing cutting-edge radiodiagnostics. 

Learn more about Lantheus's pipeline of radiopharmaceuticals for neuroendocrine tumors: 

https://www.lantheus.com/pipeline/

Submit Your Question for Lantheus
2025 ANNUAL PATIENT CONFERENCE

Confirm Your Visit to the Lantheus Virtual Booth!

​This information is for educational purposes only and does not substitute for medical advice or constitute an endorsement by NCF. Talk to your medical team about your individual care and treatment. 

NEUROENDOCRINE CANCER FOUNDATION
 
Mailing Address:
PO BOX 370466
DENVER, CO 80237

info@ncf.net
  • Facebook
  • Instagram
  • X
  • Youtube
  • LinkedIn

© 2025 by Neuroendocrine Cancer Foundation

bottom of page